ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

25,812Medicare Part D Prescriptions Filled, Including Refills

Rank: 62 out of 3593

$1.52M Total Retail Price of All Prescriptions

Rank: 46 out of 3593

973 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
62% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 973 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

21% of this provider’s 973 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 22,117 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
LEVOTHYROXINE SODIUM 1,042 931 1 4
HYDROCODONE-ACETAMINOPHEN 897 700 S3 2 7
SIMVASTATIN 880 814 3 1
FUROSEMIDE 807 740 4 9
AMLODIPINE BESYLATE 758 687 5 3
OMEPRAZOLE 680 617 6 5
LISINOPRIL 662 585 7 2
DONEPEZIL HCL 657 607 8 31
METOPROLOL TARTRATE 557 500 9 8
NAMENDA 432 394 10 50
WARFARIN SODIUM 429 399 11 18
POTASSIUM CHLORIDE 406 370 12 24
SERTRALINE HCL 405 373 13 28
ZOLPIDEM TARTRATE 404 290 14 12
CARVEDILOL 388 353 15 23
MIRTAZAPINE 379 364 16 64
CITALOPRAM HBR 310 254 17 25
TRAMADOL HCL 302 266 18 17
ATORVASTATIN CALCIUM 298 247 19 15
RISPERIDONE 297 258 20 83
GABAPENTIN 287 251 21 16
KLOR-CON M20 256 223 22 139
METFORMIN HCL 252 229 23 6
NOVOLOG 226 214 24 134
ALENDRONATE SODIUM 217 195 25 22
QUETIAPINE FUMARATE 216 204 26 89
TAMSULOSIN HCL 211 173 27 33
METOPROLOL SUCCINATE 205 176 28 19
HYDRALAZINE HCL 198 190 29 107
DIGOXIN 192 191 30 58
HYDROCHLOROTHIAZIDE 180 147 31 10
LANTUS 174 152 32 57
JANUVIA 174 157 32 81
TRAZODONE HCL 174 149 32 53
PRAVASTATIN SODIUM 173 124 35 13
CIPROFLOXACIN HCL 158 126 36 52
ADVAIR DISKUS 158 133 36 47
DIVALPROEX SODIUM 156 143 38 121
CLOPIDOGREL 151 139 39 30
AZITHROMYCIN 149 122 40 34
CRESTOR 148 96 41 21
CARBIDOPA-LEVODOPA 138 106 42 135
LYRICA 135 99 43 105
NITROFURANTOIN 133 130 44 323
LEVEMIR 133 99 44 193
NEXIUM 128 100 46 36
ESCITALOPRAM OXALATE 128 109 46 71
FLUTICASONE PROPIONATE 123 94 48 32
OXYCODONE HCL 122 58 S2 49 59
CYMBALTA 122 79 49 73
PLAVIX 122 110 49 42
ATENOLOL 120 111 52 11
DIOVAN 119 118 53 46
CLONIDINE HCL 118 97 54 41
KLOR-CON M10 115 96 55 211
ALBUTEROL SULFATE 112 112 56 157
RAMIPRIL 111 109 57 92
OXYBUTYNIN CHLORIDE ER 110 84 58 175
LOSARTAN POTASSIUM 106 104 59 14
LIDODERM 105 91 60 78
CLOTRIMAZOLE-BETAMETHASONE 104 85 61 94
LEVOFLOXACIN 104 99 61 116
RANITIDINE HCL 100 81 63 27
LACTULOSE 96 83 64 126
PANTOPRAZOLE SODIUM 96 78 64 45
PREDNISONE 96 93 64 49
FENTANYL 94 75 S2 67 137
OXYCODONE HCL-ACETAMINOPHEN 93 44 S2 68 82
CELEBREX 91 83 69 100
OLANZAPINE 91 78 69 198
OXYBUTYNIN CHLORIDE 89 81 71 104
CEPHALEXIN 85 77 72 150
ACTOS 85 78 72 133
PROMETHAZINE HCL 83 70 R 74 142
FLUOXETINE HCL 82 80 75 60
METRONIDAZOLE 81 66 76 268
EXELON 81 81 76 123
NITROFURANTOIN MONO-MACRO 79 74 78 242
SEROQUEL 77 74 79 172
ALLOPURINOL 76 60 80 35
PROAIR HFA 75 53 81 54
DETROL LA 74 72 82 262
SPIRIVA 74 59 82 87
TRICOR 73 43 84 130
CARISOPRODOL 69 0 R 85 97
CYCLOBENZAPRINE HCL 68 47 R 86 72
OXYCODONE-ACETAMINOPHEN 67 61 S2 87 93
PAROXETINE HCL 66 58 88 62
VESICARE 66 65 88 205
GLIPIZIDE 65 55 90 40
VENLAFAXINE HCL ER 64 50 91 178
ISOSORBIDE MONONITRATE ER 63 63 92 61
MEGESTROL ACETATE 63 63 R 92 152
LATANOPROST 62 62 94 195
LOVASTATIN 61 56 95 20
GLIMEPIRIDE 61 40 95 44
AMOX TR-POTASSIUM CLAVULANATE 59 51 97 138
PRADAXA 59 53 97 325
PROPRANOLOL HCL 58 53 99 181
NIFEDIPINE ER 57 57 100 75
SPIRONOLACTONE 56 32 101 86
TIZANIDINE HCL 56 40 101 120
NOVOLIN R 56 54 101 140
PHENYTOIN SODIUM EXTENDED 55 55 104 165
MELOXICAM 54 53 105 29
METHADONE HCL 54 19 S2 105 158
FLUCONAZOLE 54 44 105 229
IPRATROPIUM-ALBUTEROL 54 53 105 154
NIASPAN 52 29 109 186
DILTIAZEM HCL 52 52 109 250
AMIODARONE HCL 52 44 109 269
NYSTATIN 51 48 112 167
MONOJECT INSULIN SAFETY SYRNG 51 51 112 472
ROPINIROLE HCL 50 18 114 144
METHYLPREDNISOLONE 50 42 114 103
FINASTERIDE 50 41 114 79
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 4, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.